The ability of the SCORE high-risk model to predict 10-year cardiovascular disease mortality in Norway

Aims To evaluate the predictive accuracy of the Systematic Coronary Risk Evaluation (SCORE) project high-risk function in Norway. Methods and results We included 57229 individuals screened in 1985-1992 from two population-based surveys in Norway (age groups 40-49, 50-59, and 60-69 years). The data have been linked to the Norwegian Cause of Death Registry. The SCORE high-risk algorithm for the prediction of 10-year cardiovascular disease (CVD) mortality was applied, and the risk factors entered into the model were age, sex, total cholesterol, systolic blood pressure, and smoking (yes/no). The number of expected events estimated by the SCORE model (E) was compared with the observed numbers (O). The SCORE low-risk algorithm was studied for comparison. In men, the observed number of CVD deaths was 718, compared with 1464 estimated by the SCORE high-risk function (O/E ratios 0.53, 0.53 and 0.45, for age groups 40-49, 50-59 and 60-69, respectively). In women, the observed and expected numbers were 226 and 547. The O/E ratios decreased with age (ratios 0.60, 0.45 and 0.37, respectively), i.e. the overestimation increased with age. The low-risk function predicted reasonably well for men (ratios 0.85, 0.92 and 0.79, respectively), whereas an overestimation was found for women aged 50-59 and 60-69 years (ratios 0.69 and 0.56, respectively). Conclusion The SCORE high-risk model overestimated the number of CVD deaths in Norway. Before implementation in clinical practice, proper adjustments to national levels are required.

[1]  P E Puddu,et al.  Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. , 2000, European heart journal.

[2]  H. Hense Observations, predictions and decisions--assessing cardiovascular risk assessment. , 2004, International journal of epidemiology.

[3]  P. Poole‐Wilson,et al.  [Prevention of coronary disease in clinical practice. Recommendations of the Task-Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension]. , 1995, Annales de cardiologie et d'angeiologie.

[4]  S. Graff-Iversen,et al.  Cardiovascular risk factors in Norwegian women using oral contraceptives: results from a cardiovascular health screening 1985-88. , 1996, Contraception.

[5]  B Cazelles,et al.  Estimation of CHD risk in a French working population using a modified Framingham model. The PCV-METRA Group. , 1994, Journal of clinical epidemiology.

[6]  Tom Fahey,et al.  Predictive accuracy of the Framingham coronary risk score in British men:prospective cohort study , 2003, BMJ : British Medical Journal.

[7]  L. Wilhelmsen,et al.  [The Swedish SCORE chart for cardiovascular risk. Better possibilities for prevention of cardiovascular diseases]. , 2004, Lakartidningen.

[8]  K. Anderson,et al.  An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.

[9]  Helmut Schulte,et al.  Framingham risk function overestimates risk of coronary heart disease in men and women from Germany--results from the MONICA Augsburg and the PROCAM cohorts. , 2003, European heart journal.

[10]  H. Hense Risk factor scoring for coronary heart disease , 2003, BMJ : British Medical Journal.

[11]  T. Jørgensen,et al.  A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. , 2002, International journal of epidemiology.

[12]  L. Getz,et al.  Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study , 2005, BMJ : British Medical Journal.

[13]  K. Anderson,et al.  Cardiovascular disease risk profiles. , 1991, American heart journal.

[14]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[15]  J Marrugat,et al.  An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas , 2003, Journal of epidemiology and community health.

[16]  A. Eggen,et al.  Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001. , 2005, European heart journal.

[17]  H. Concin,et al.  Predictive accuracy of the SCORE risk function for cardiovascular disease in clinical practice: a prospective evaluation of 44 649 Austrian men and women , 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[18]  Ian Graham,et al.  Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. , 1998, European heart journal.

[19]  B. Kirkhus,et al.  [Diet changes and the rise and fall of cardiovascular disease mortality in Norway]. , 2004, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[20]  A. Eggen,et al.  The SCORE risk model applied to recent population surveys in Norway compared to observed mortality in the general population , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[21]  G. Mancia,et al.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). , 2004, Atherosclerosis.

[22]  A. Tverdal,et al.  [Screening of 40-year-olds--400,000 men and women attended]. , 2002, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[23]  H. Neuhauser,et al.  A comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and Examination Survey 1998 , 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[24]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. , 2003 .

[25]  R. Nicolaysen,et al.  Ten-year mortality and morbidity related to serum cholesterol. A follow-up of 3.751 men aged 40-49. , 1972, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[26]  A. Majeed Thresholds for normal blood pressure and serum cholesterol , 2006 .

[27]  P. Whincup,et al.  Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. , 2004, European heart journal.

[28]  G. Chatellier,et al.  The Framingham prediction rule is not valid in a European population of treated hypertensive patients , 2002, Journal of hypertension.

[29]  S. Graff-Iversen,et al.  Cardiovascular risk factors in Norwegian women using oral contraceptives: Results from a cardiovascular health screening 1985–1988 , 1996 .

[30]  K. Bjartveit,et al.  The cardiovascular disease study in Norwegian counties. Results from first screening. , 1983, Acta medica Scandinavica. Supplementum.

[31]  R. D'Agostino,et al.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.

[32]  GerdAssmann,et al.  Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002 .

[33]  P Ducimetière,et al.  Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. , 2003, European heart journal.

[34]  F. Rodríguez‐Artalejo,et al.  [Spanish adaptation of the European Guidelines on Cardiovascular Disease Prevention]. , 2004, Neurologia.

[35]  R. Selmer Blood pressure and twenty-year mortality in the city of Bergen, Norway. , 1992, American journal of epidemiology.

[36]  G. De Backer,et al.  [Recommendations for the prevention of cardiovascular diseases in clinical practice]. , 2005, Journal de pharmacie de Belgique.

[37]  P. Poole‐Wilson,et al.  Prevention of coronary heart disease in clinical practice , 1994 .